logo

Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive-hyperactive symptoms: an open-label trial.

This page provides detailed information about this publication. Please click on any text which is underlined to find more information.


Authors
Pavel Golubchik, Jonathan Sever, Abraham Weizman
Title
Reboxetine treatment for autistic spectrum disorder of pediatric patients with depressive and inattentive-hyperactive symptoms: an open-label trial.
Journal
Clinical Neuropharmacology
Year
2013
Month
March
Volume
36
Issue
2
Page(s)
pp. 37-41.
Abstract Link
Read Abstract (New Window)
Publication Format
Journal Article
Efficacy Study/Review
Yes
Scientific Validity
Open Trial, Peer-Reviewed
Keywords
Adolescent / Secondary School Age, Antidepressants, Asperger Syndrome, Attention Deficit Hyperactivity Disorder, Autism, Child/Children, Depression, Development, Hyperactivity, Intervention, Medication, Pervasive Developmental Disorder (Not Otherwise Specified), Primary / Elementary School Age, Reboxetine, Selective Noradrenaline Re-Uptake Inhibitor, Uptake

Please note that we are unable to supply publications unless we are listed as the publisher. However, if you are a UK resident you may be able to obtain them from your local public library, your college library or direct from the publisher.


Publications | Publications Database | Search Publications